by Eric Christianson | Oct 3, 2021 | Medication and Disease State Clinical Pearls For Pharmacists
Patients will frequently ask me what supplements they should use to help treat their conditions and more often, they begin to take something even prior to asking. I was recently asked my thoughts on glucosamine and chondroitin for arthritis, and more specifically,...
by Eric Christianson | Sep 26, 2021 | Medication and Disease State Clinical Pearls For Pharmacists
Ezetimibe (Zetia) is a medication used to lower cholesterol. More specifically, this medication is used in clinical practice to lower LDL and help get patients to a target goal. If you recall from your pharmacology classes, ezetimibe inhibits the absorption of...
by Eric Christianson | Sep 22, 2021 | Medication and Disease State Clinical Pearls For Pharmacists
Vibegron (Gemtesa) is a selective beta-3 adrenergic receptor agonist. It treats OAB, including urge urinary incontinence and urinary frequency by relaxing the detrusor smooth muscle during bladder filling. Thus, increasing bladder capacity. Vibegron is dosed once...
by Eric Christianson | Sep 19, 2021 | Medication and Disease State Clinical Pearls For Pharmacists
I’ve been asked in the past about making recommendations with regards to urinary frequency. Trospium has an advantage over other anticholinergic agents that many do not know about or forget about. Before I discuss this advantage, I definitely want to encourage...
by Eric Christianson | Sep 8, 2021 | Medication and Disease State Clinical Pearls For Pharmacists
Polymyalgia rheumatica (PMR) is a relatively common condition in adults over 50 years old, and more often affects northern European populations including Scandinavians, although it can affect people of any race. Below we will outline the basics of the treatment of...
by Eric Christianson | Sep 1, 2021 | Medication and Disease State Clinical Pearls For Pharmacists
At the end of July, the FDA approved Semglee (insulin glargine-yfgn) as the first-ever interchangeable drug in the United States. It is essentially a copy of Lantus, a long-acting basal insulin. Patients will have questions about the interchangeable status of...
